Methylation of the paired-like homeodomain transcription factor 2 (PITX2) has been successfully proven a powerful prognostic biomarker in several cancer entities such as lung cancer [12], hormone-receptor-negative breast cancer [13–16], and PCa [17–19]. Here, PITX2 is linked to lung cancer.